跳至主要内容
临床试验/EUCTR2015-002540-13-CZ
EUCTR2015-002540-13-CZ进行中(未招募)1 期

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris - Double-Blind Efficacy and Safety of CD5789 50µg/g Cream versus Vehicle Cream in Acne Vulgaris

Galderma R&D SNC0 个研究点目标入组 1,200 人开始时间: 2015年11月3日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
1,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. Male or female, 9 years of age and older, at the Screening visit.
  • 2. The Subject has a facial acne severity grade of 3 (moderate) on the Investigator Global Assessment (IGA) scale at Screening and Baseline.
  • 3. The subject has a minimum of 20 inflammatory lesions and 25 noninflammatory lesions on the face at Screening and Baseline.
  • 4. The subject has truncal acne severity grade of 3 (moderate) on the Physician Global assessment (PGA) scale at Screening and Baseline visits on trunk (shoulders, upper back and upper anterior chest) reachable for self-application of study drug by the subject (optional criterion for subject between 9 and 11 years of age).
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 478
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 2

排除标准

  • 1. The subject has severe forms of acne (e.g., acne conglobata, acne fulminans) or secondary acne form (e.g.,chloracne, drug-induced acne, etc.).
  • 2. The subject has more than 1 nodule on the face at Screening and Baseline.
  • 3. The subject has more than 1 nodule on the trunk at Screening and Baseline.
  • 4. The subject has any acne cyst on the trunk at Screening and at Baseline

研究者

发起方
Galderma R&D SNC

相似试验

进行中(未招募)
1 期
Studying the Effects of 50 µg/g Cream versus Vehicle on Subjects who have Acne.
EUCTR2015-002540-13-HUGalderma R&D SNC1,200
进行中(未招募)
1 期
A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris
EUCTR2015-002540-13-ESGalderma R&D SNC1,200
进行中(未招募)
1 期
A clinical trial for rosacea patients. The study medication will be a low dose antibiotics or placebo, which will be administered orally. Both the study doctors and clinical trial participants don't know which treatment is being administered, there will be 4 treatment groups.The safety and efficacy of the medicinal product will be tested during the study.Inflammatory Lesions of papulopustular RosaceaMedDRA version: 20.0Level: PTClassification code 10076537Term: Papulopustular rosaceaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disorders
EUCTR2016-003197-41-DEDr. Reddy's Labaratories Ltd.205
进行中(未招募)
1 期
Studying the Effects of 50µg/g Cream versus Placebo on Patients who have AcneAcne VulgarisMedDRA version: 20.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 100000004858
EUCTR2016-002860-15-CZGalderma R&D SNC1,208
进行中(未招募)
1 期
Studying the Effects of 50µg/g Cream versus Placebo on Patients who have AcneAcne VulgarisMedDRA version: 20.0Level: LLTClassification code 10000519Term: Acne vulgarisSystem Organ Class: 100000004858
EUCTR2016-002860-15-DEGalderma R&D SNC1,200